Fundraising FoxAraris Biotech
Basel, CH · 7 known investors
Find your way into Araris Biotech
Sign up to see every warm intro you have to Araris Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Araris Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Araris develops proprietary antibody-drug conjugate (ADC) linker technology that enables one-step attachment of payloads to native antibodies for targeted cancer therapy. The platform generates stable, homogenous ADCs for oncology applications without requiring antibody re-engineering.
Founders & leadership
DG
Dragan GrabulovskiCo-founder and CEODragan Grabulovski is co-founder and CEO of Araris Biotech, which develops antibody-drug conjugate linker technology for targeted cancer therapy. He previously co-founded Covagen, which was sold to Johnson & Johnson in 2014.
Investors · 7
Pureos Bioventures✓ confirmed by Araris BiotechPfäffikon
How we know: the company's own site · a partner's Signal profile · Not right? Tell us
redalpine✓ confirmed by Araris BiotechZug · $108K – $2.2M
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Samsung Ventures✓ confirmed by Araris BiotechSeoul
How we know: the company's own site · Not right? Tell us
In the news
Frequently asked questions
- What does Araris Biotech do?
- Araris develops proprietary antibody-drug conjugate (ADC) linker technology that enables one-step attachment of payloads to native antibodies for targeted cancer therapy. The platform generates stable, homogenous ADCs for oncology applications without requiring antibody re-engineering.
- Who founded Araris Biotech?
- Araris Biotech was founded by Dragan Grabulovski, Philipp Spycher, Isabella Attinger-Toller.
- Who are Araris Biotech's investors?
- Araris Biotech's investors include Pureos Bioventures, redalpine, Samsung Ventures, VI Partners, b2venture, Kinled Holding, 4BIO Capital.
- Where is Araris Biotech headquartered?
- Araris Biotech is headquartered in Basel, CH.